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Letter to the Editor
Systematic reviews comparing the effect of high-flow
nasal treatment (HFNT) to conventional oxygen therapy
(COT) or noninvasive ventilation (NIV) have focused on
major clinical outcomes (i.e., endotracheal intubation,
mortality) [1–3]. None have explored weaker outcomes
that may nonetheless be important from the patient’s
perspective, yet physiopathological mechanisms suggest
that the HFNT may provide some advantage in this re-
gard [4, 5]. We therefore systematically reviewed all ran-
domized (RCTs) and crossover trials enrolling patients
either post-extubation or during acute respiratory failure
(ARF), comparing HFNT to COT or NIV and reporting
data about dyspnea, comfort, and respiratory rate (RR)
(PROSPERO CRD42019119536).
Full search strategy, detailed study methods, reference
lists, and risk of bias assessments are reported in
Additional file 1.
Twenty-four relevant studies were identified and in-
cluded: for patients post-extubation, ten RCTs and one
crossover trial and, for patients in ARF, eight RCTs and
five crossover trials.
The summary of our findings is presented in the
Table 1. More studies compared the effects of HNFT
vs COT rather than vs NIV. Overall, there seems to
be a trend showing that HFNT is probably not infer-
ior to COT in most studies and perhaps better than
NIV in terms of dyspnea, comfort, and decreasing of
RR in some studies.
Heterogeneity in case-mix, the tools used for out-
come assessment and measurement time-points
precluded performance of meta-analysis. Neither pa-
tients nor treating clinicians were blinded to the
intervention in any of the trials, introducing a high
risk of detection bias. Differences in HFNT settings
(i.e., flow and temperature) and a lack of full
description for weaning criteria or protocol may
have also contributed to the diversity in findings
with regard to comfort and dyspnea.
In this analysis of the literature, the use of HFNT
during ARF or post-extubation seems to be not
clearly associated with improvements in comfort,
dyspnea, and RR since findings from the most recent
available evidence were inconsistent. However, in this
regard, HFNT does not seem inferior to either COT
or NIV. Future research should be focused in asses-
sing patient-reported outcomes using appropriate
standardized and validated measures in order to
investigate the comparative effectiveness of the dif-
ferent respiratory support strategies.
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